Zobrazeno 1 - 10
of 131
pro vyhledávání: '"S. A Noskov"'
Autor:
S. I. Noskov, Yu. A. Bychkov
Publikováno v:
Вестник Дагестанского государственного технического университета: Технические науки, Vol 51, Iss 3, Pp 117-122 (2024)
Objective. The purpose of the study is to solve the problem of calculating the parameters of a linear regression model based on the joint application of anti-robust estimation methods and maximum consistency between the real and calculated values of
Externí odkaz:
https://doaj.org/article/569b2fc76bc74ed79a779efe60700bc0
Autor:
I. E. Shohin, S. M. Noskov, A. A. Globenko, N. S. Bagaeva, K. K. Karnakova, O. M. Parulya, L. N. Lutskova, A. V. Kapashin, M. A. Pasko
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 2, Pp 3-11 (2024)
Aim. A comparative study of the pharmacokinetics and safety of the investigational drug Duonica®, enteric-soluble, film-coated tablets, 10 mg + 10 mg (Valenta Pharm JSC, Russia) and the reference drug Diclectin®, delayed-release tablets, 10 mg + 10
Externí odkaz:
https://doaj.org/article/ba3dd3d5222342d0a032d8d0a620c8b6
Autor:
S. I. Noskov, S. I. Belinskaya
Publikováno v:
Вестник Дагестанского государственного технического университета: Технические науки, Vol 50, Iss 4, Pp 115-120 (2024)
Objective. The aim of the study is to develop an algorithm for identifying the parameters of a homogeneous nested piecewise linear regression model of the first type by the method of least modules. Method. Estimation of its unknown parameters is carr
Externí odkaz:
https://doaj.org/article/f92be8d735344aac8a53016053c48b3c
Autor:
A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, V. S. Scherbakova, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, E. Yu. Kesova, E. D. Kozlov, E. S. Samoshkina, D. N. Andreev, Yu. G. Kazaishvili, S. M. Noskov, L. A. Balykova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 324-346 (2024)
Semaglutide is a representative of analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently used in Russia for the treatment of type 2 diabetes mellitus (T2DM; in monotherapy and in combination therapy), including pati
Externí odkaz:
https://doaj.org/article/c34ff57fdc98416a8dce0a84dbcfc85b
Autor:
A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, S. M. Noskov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 255-276 (2023)
Liraglutide is one of the analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently a priority treatment for diseases such as type 2 diabetes mellitus (mono- and combination therapy), obesity and overweight in the prese
Externí odkaz:
https://doaj.org/article/2594ff78904340c69eb6d062f929ba86
Autor:
A. N. Arevefa, A. R. Dorotenko, S. M. Noskov, I. E. Makarenko, R. V. Drai, T. N. Komarov, O. A. Archakova, N. S. Bagaeva, I. E. Shokhin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 3, Pp 218-227 (2023)
Introduction. Citicoline is an endogenous nucleoside consisting of cytidine and choline linked by a diphosphate bridge that is involved in the synthesis of membrane phospholipids. Drugs containing citicoline have neuroprotective and neurometabolic ef
Externí odkaz:
https://doaj.org/article/ccf7fc38cfed460b835470037a54f63e
Publikováno v:
Вестник Дагестанского государственного технического университета: Технические науки, Vol 50, Iss 1, Pp 123-129 (2023)
Objective. The aim of the study is to build a linear regression model of electricity generation in the Russian Federation depending on resource indicators, which include: the volume of coal and gas production, the production of fuel oil. Statistical
Externí odkaz:
https://doaj.org/article/40cf85ef47ef4977a0df635ed3c84b05
Autor:
L. A. Balykova, N. M. Selezneva, E. I. Gorshenina, O. I. Shepeleva, N. V. Kirichenko, E. N. Simakina, K. B. Kolontarev, D. Yu. Pushkar, D. N. Zemskov, K. Ya. Zaslavskaya, S. M. Noskov, A. V. Taganov, P. A. Bely
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 4, Pp 371-386 (2022)
The article presents the data from an open, two-stage, multicenter study on the efficacy and safety evaluation of a combined drug (a fixed combination of nirmatrelvir 300 mg and ritonavir 100 mg) in the complex therapy in COVID-19 patients.The aim of
Externí odkaz:
https://doaj.org/article/f0537436ed604faab74f945d68d08d55
Publikováno v:
Спортивная медицина: наука и практика, Vol 9, Iss 4, Pp 67-73 (2020)
The number of women and the elderly has now increased among marathon runners. This cohort has a high risk of osteoarthritis development. The hypothesis, based on little scientific evidence, is that the additional stress on knee joints that occurs dur
Externí odkaz:
https://doaj.org/article/d60df7d060e344fe8edb3b2593b41685
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 224-230 (2020)
The use of magnetic resonance imaging (MRI) for osteoarthritis made it possible to simultaneously detail the state of cartilage, subchondral bone, menisci, ligaments, and synovial membrane. In some studies, a correlation was found between bone marrow
Externí odkaz:
https://doaj.org/article/9285edf4a8d0425d9d8f53bf23436034